Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4eqc | XR1 | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4eqc | XR1 | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 1.000 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.538 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.531 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.527 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.519 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.514 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.512 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.511 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.509 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.509 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.509 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.508 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.504 | |
| 2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.504 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.504 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.503 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.502 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.501 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.500 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.499 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
| 3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.498 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.496 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.494 | |
| 4hjf | C2E | GGDEF family protein | / | 0.494 | |
| 2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.491 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
| 3t5i | SER_SER_CMT_FAR | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.490 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.490 | |
| 4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.490 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.487 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.487 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.486 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.485 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.485 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.485 | |
| 5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.485 | |
| 3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.484 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
| 2ba9 | FAD | Putative aminooxidase | / | 0.483 | |
| 4s33 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.483 | |
| 4s34 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.483 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.482 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.482 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.481 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.481 | |
| 2oye | IM8 | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.480 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.480 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.480 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 3vqv | ANP | Pyrrolysine--tRNA ligase | / | 0.479 | |
| 4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.478 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.478 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.478 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.478 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.477 | |
| 4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.477 | |
| 4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.477 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.476 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.476 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.476 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.476 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.475 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.475 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
| 4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.475 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.474 | |
| 3n8w | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.474 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 4crs | AGS | Serine/threonine-protein kinase N2 | 2.7.11.13 | 0.474 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.474 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.473 | |
| 3orn | 3OR | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.473 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 4b1f | KRH | Glutamate racemase | / | 0.473 | |
| 1mab | ATP | ATP synthase subunit alpha, mitochondrial | / | 0.472 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.472 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.472 | |
| 3e9h | KAA | Lysine--tRNA ligase | 6.1.1.6 | 0.472 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.472 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.472 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.472 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.472 | |
| 4pd6 | URI | Nucleoside permease | / | 0.472 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.471 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.471 | |
| 4bva | T3 | Ketimine reductase mu-crystallin | 1.5.1.25 | 0.471 | |
| 4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.471 | |
| 4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.471 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.471 | |
| 4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.471 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.471 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.470 | |
| 2b9w | FAD | Putative aminooxidase | / | 0.469 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.469 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 3n8z | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.469 | |
| 5jqb | IBP | Envelope glycoprotein | / | 0.469 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.468 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.468 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.468 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.468 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.468 | |
| 1ht8 | 34C | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.467 | |
| 3kk6 | CEL | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.467 | |
| 4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.467 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.467 | |
| 1a5u | ATP | Pyruvate kinase PKM | 2.7.1.40 | 0.466 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.466 | |
| 2v51 | LAB | Actin, alpha skeletal muscle | / | 0.466 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.466 | |
| 3pcf | FHB | Protocatechuate 3,4-dioxygenase beta chain | 1.13.11.3 | 0.466 | |
| 3uwq | U5P | Orotidine 5'-phosphate decarboxylase | / | 0.466 | |
| 4cox | IMN | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.466 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
| 3qls | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.465 | |
| 4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.465 | |
| 4pl4 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.465 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.465 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.464 | |
| 1ml6 | GBX | Glutathione S-transferase A2 | 2.5.1.18 | 0.464 | |
| 1psd | NAD | D-3-phosphoglycerate dehydrogenase | 1.1.1.95 | 0.464 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 2qo6 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.464 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.464 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 5j3w | FMN | Sensory box protein | / | 0.464 | |
| 1osv | CHC | Bile acid receptor | / | 0.463 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.463 | |
| 2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.463 | |
| 4an3 | 5Y0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.463 | |
| 4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.463 | |
| 4bwx | AGS | PAB-dependent poly(A)-specific ribonuclease subunit pan3 | / | 0.463 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.463 | |
| 4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
| 4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.463 | |
| 4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.463 | |
| 4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.463 | |
| 1yin | CM3 | Estrogen receptor | / | 0.462 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.462 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.462 | |
| 4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
| 4pl3 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.462 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
| 1d3g | BRE | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.461 | |
| 2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 4an9 | 2P7 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.461 | |
| 5j4e | FMN | Sensory box protein | / | 0.461 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 2nom | DUT | Poly(A) polymerase, putative | / | 0.460 | |
| 3aox | EMH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.460 | |
| 3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
| 4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.460 | |
| 4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.460 | |
| 5aut | 2AN | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
| 1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.459 | |
| 1qo8 | FAD | Fumarate reductase flavoprotein subunit | / | 0.459 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.459 | |
| 3c5u | P41 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3pju | C2E | Diguanylate cyclase/phosphodiesterase | / | 0.459 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.459 | |
| 4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.459 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.459 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.459 | |
| 1eqg | IBP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.458 | |
| 1ot7 | CHC | Bile acid receptor | / | 0.458 | |
| 1uom | PTI | Estrogen receptor | / | 0.458 | |
| 1ydr | IQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
| 2cbs | R13 | Cellular retinoic acid-binding protein 2 | / | 0.458 | |
| 2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.458 | |
| 3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3nc9 | TR3 | Ketohexokinase | / | 0.458 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.458 | |
| 4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
| 4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
| 5ej7 | TD6 | 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase | / | 0.458 | |
| 2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.457 | |
| 3dk4 | NDP | Glutathione reductase, mitochondrial | 1.8.1.7 | 0.457 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
| 3zcw | 4A2 | Kinesin-like protein KIF11 | / | 0.457 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.457 | |
| 4gyi | ADP | Uncharacterized protein | / | 0.457 | |
| 4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 1lri | CLR | Beta-elicitin cryptogein | / | 0.456 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 2b9x | FAD | Putative aminooxidase | / | 0.456 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 3mec | 65B | Gag-Pol polyprotein | 2.7.7.49 | 0.456 | |
| 4at8 | ATP | Interleukin enhancer-binding factor 2 | / | 0.456 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.456 | |
| 1hk2 | T44 | Serum albumin | / | 0.455 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 1ztf | XYA | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.455 | |
| 2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.455 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.455 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.455 | |
| 2vo0 | M03 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.455 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
| 3cly | ACP | Fibroblast growth factor receptor 2 | / | 0.455 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.455 | |
| 5dg3 | U21 | Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase | / | 0.455 | |
| 5ej6 | TD6 | 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase | / | 0.455 | |
| 1eqh | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.454 | |
| 1rdt | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.454 | |
| 1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.454 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.454 | |
| 2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.454 | |
| 2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.454 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.454 | |
| 4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
| 4ivg | ANP | TNF receptor-associated protein 1 | / | 0.454 | |
| 4l98 | LRG | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
| 4nu6 | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.454 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.454 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
| 1v9a | SAH | Uncharacterized protein | / | 0.453 | |
| 2hzi | JIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.453 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.453 | |
| 2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.453 | |
| 2ooy | ATP | 5'-AMP-activated protein kinase subunit gamma | / | 0.453 | |
| 2ybo | SAH | Methyltransferase | / | 0.453 | |
| 2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
| 2yx1 | SFG | tRNA (guanine(37)-N1)-methyltransferase Trm5b | 2.1.1.228 | 0.453 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.453 | |
| 3tm5 | SFG | Uncharacterized protein | / | 0.453 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.453 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
| 4be7 | ATP | Type I restriction enzyme EcoR124II R protein | 3.1.21.3 | 0.453 | |
| 4f9m | FCM | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.453 | |
| 4kko | 1RE | Gag-Pol polyprotein | 2.7.7.49 | 0.453 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.453 | |
| 4wbb | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 1efp | FAD | Electron transfer flavoprotein subunit alpha | / | 0.452 | |
| 1lj8 | NAD | Mannitol dehydrogenase | / | 0.452 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.452 | |
| 2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
| 2v3a | FAD | Rubredoxin-NAD(+) reductase | 1.18.1.1 | 0.452 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
| 2w2l | NAD | D-mandelate dehydrogenase | / | 0.452 | |
| 3a4l | ANP | L-seryl-tRNA(Sec) kinase | 2.7.1.164 | 0.452 | |
| 3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.452 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.452 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.452 | |
| 3pff | ADP | ATP-citrate synthase | 2.3.3.8 | 0.452 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.452 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.452 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.452 | |
| 4m11 | MXM | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.452 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.452 | |
| 4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.452 | |
| 5ej9 | TPP | 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase | / | 0.452 | |
| 1gox | FMN | Peroxisomal (S)-2-hydroxy-acid oxidase | 1.1.3.15 | 0.451 | |
| 1qvn | FRI | Interleukin-2 | / | 0.451 | |
| 1tl3 | H20 | Gag-Pol polyprotein | 2.7.7.49 | 0.451 | |
| 2b00 | GCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.451 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 3ka7 | FAD | Putative oxidoreductase | / | 0.451 | |
| 3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
| 4b1v | ATP | Actin, alpha skeletal muscle | / | 0.451 | |
| 4ffr | ATP | Uncharacterized protein | / | 0.451 | |
| 1esv | LAR | Actin, alpha skeletal muscle | / | 0.450 | |
| 1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.450 | |
| 2bx8 | AZQ | Serum albumin | / | 0.450 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.450 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.450 | |
| 3gbk | 2PQ | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
| 3njo | P2M | Abscisic acid receptor PYR1 | / | 0.450 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.450 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.450 | |
| 4u7t | SAH | DNA (cytosine-5)-methyltransferase 3A | 2.1.1.37 | 0.450 | |
| 4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
| 5c1p | ADP | D-alanine--D-alanine ligase | / | 0.450 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.449 | |
| 1fk9 | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.449 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 2ydf | IO3 | Serum albumin | / | 0.449 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3gcu | R48 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3lu8 | IQX | Serum albumin | / | 0.449 | |
| 3pgh | FLP | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.449 | |
| 3vsp | EK8 | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
| 1bcp | ATP | Pertussis toxin subunit 4 | / | 0.448 | |
| 1bcp | ATP | Pertussis toxin subunit 5 | / | 0.448 | |
| 1ewy | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.448 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.448 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
| 2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
| 2zza | FOL | Dihydrofolate reductase | / | 0.448 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
| 3cnt | FAD | Polyamine oxidase FMS1 | / | 0.448 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.448 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.448 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.448 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.448 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 4oti | MI1 | Serine/threonine-protein kinase N1 | / | 0.448 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.448 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.447 | |
| 1rc0 | KT5 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.447 | |
| 1rrm | APR | Lactaldehyde reductase | 1.1.1.77 | 0.447 | |
| 2b9y | FAD | Putative aminooxidase | / | 0.447 | |
| 2g5c | NAD | Prephenate dehydrogenase | / | 0.447 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
| 3cyz | 9OD | Pheromone-binding protein ASP1 | / | 0.447 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3hv4 | L51 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3ix9 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.447 | |
| 3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.447 | |
| 3pjt | C2E | Diguanylate cyclase/phosphodiesterase | / | 0.447 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.447 | |
| 3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.447 | |
| 4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.447 | |
| 4lxh | C1E | Alpha/beta hydrolase fold | / | 0.447 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.447 | |
| 5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.447 | |
| 5dju | FMN | NPH1-2 | / | 0.447 | |
| 1e94 | ANP | ATP-dependent protease ATPase subunit HslU | / | 0.446 | |
| 1hrv | SDZ | Genome polyprotein | / | 0.446 | |
| 1njf | AGS | DNA polymerase III subunit tau | 2.7.7.7 | 0.446 | |
| 2xtz | GSP | Guanine nucleotide-binding protein alpha-1 subunit | / | 0.446 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
| 3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.446 | |
| 3lov | FAD | Protoporphyrinogen oxidase | / | 0.446 | |
| 3meg | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
| 4e5n | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.446 | |
| 4fk8 | FAD | Ferredoxin--NADP reductase | / | 0.446 | |
| 4fxf | ATP | Pyruvate kinase PKM | 2.7.1.40 | 0.446 | |
| 4gnc | ASO | Regucalcin | 3.1.1.17 | 0.446 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.446 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
| 4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 1ai9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 1hk4 | T44 | Serum albumin | / | 0.445 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 1rbq | KEU | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.445 | |
| 1sn5 | T3 | Transthyretin | / | 0.445 | |
| 2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
| 3anm | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.445 | |
| 3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.445 | |
| 3qa2 | XNA | Ketohexokinase | / | 0.445 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
| 4mv8 | ACP | Biotin carboxylase | 6.3.4.14 | 0.445 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.445 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.445 | |
| 1b15 | NAE | Alcohol dehydrogenase | 1.1.1.1 | 0.444 | |
| 1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 1fbm | RTL | Cartilage oligomeric matrix protein | / | 0.444 | |
| 1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 2ewp | TXF | Estrogen-related receptor gamma | / | 0.444 | |
| 2nnl | NAP | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.444 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.444 | |
| 3hng | 8ST | Vascular endothelial growth factor receptor 1 | 2.7.10.1 | 0.444 | |
| 3mee | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
| 3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 | 0.444 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 4o8f | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2bxe | 1FL | Serum albumin | / | 0.443 | |
| 2cdu | FAD | NADH oxidase | / | 0.443 | |
| 2gej | GDD | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.443 | |
| 2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
| 2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.443 | |
| 3av7 | KYA | Uncharacterized protein | / | 0.443 | |
| 3buz | LAR | Actin, alpha skeletal muscle | / | 0.443 | |
| 3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
| 3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
| 3ujl | A8S | Abscisic acid receptor PYL2 | / | 0.443 | |
| 3vqx | BLK | Pyrrolysine--tRNA ligase | / | 0.443 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.443 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 1dkf | BMS | Retinoic acid receptor alpha | / | 0.442 | |
| 1gd1 | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.442 | |
| 1uyu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2e2b | 406 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.442 | |
| 2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
| 2qim | ZEA | Class 10 plant pathogenesis-related protein | / | 0.442 | |
| 2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
| 3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
| 3dau | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.442 | |
| 3gcs | BAX | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 3nwy | GTP | Uridylate kinase | / | 0.442 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 4d9t | 0JG | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.442 | |
| 4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.442 | |
| 4feh | FAD | Decaprenylphosphoryl-beta-D-ribose oxidase | / | 0.442 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4i6a | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.88 | 0.442 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.442 | |
| 4k2r | ANP | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.442 | |
| 4mxe | ACO | N-acetyltransferase ESCO1 | 2.3.1 | 0.442 | |
| 4nr4 | 2LK | CREB-binding protein | / | 0.442 | |
| 4wq5 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.442 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.442 | |
| 1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.441 | |
| 1knu | YPA | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 1rfq | LAR | Actin, alpha skeletal muscle | / | 0.441 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.441 | |
| 2c9c | ATP | Psp operon transcriptional activator | / | 0.441 | |
| 2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.441 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3c3d | FO1 | 2-phospho-L-lactate transferase | / | 0.441 | |
| 3d7k | D7K | Benzaldehyde lyase | / | 0.441 | |
| 3h1j | SMA | Cytochrome b | / | 0.441 | |
| 3jzd | NAD | Maleylacetate reductase | / | 0.441 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 3v01 | 3V0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.441 | |
| 3vso | EK1 | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 3zvv | XAZ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 4e5k | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.441 | |
| 4lrj | ANP | Uncharacterized protein | / | 0.441 | |
| 4nxv | GDP | Mitochondrial dynamics protein MID51 | / | 0.441 | |
| 4oau | ADP | 2-5A-dependent ribonuclease | 3.1.26 | 0.441 | |
| 4tvb | NAD | Homospermidine synthase | 2.5.1.44 | 0.441 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.441 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.440 | |
| 1kzu | RG1 | Light-harvesting protein B-800/850 alpha chain | / | 0.440 | |
| 1kzu | RG1 | Light-harvesting protein B-800/850 beta chain | / | 0.440 | |
| 2ayl | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.440 | |
| 2dji | FAD | Pyruvate oxidase | / | 0.440 | |
| 2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
| 2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 3dtw | A96 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
| 3fpb | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.440 | |
| 3ncz | 3NC | Rho-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3opd | HIE | Heat shock protein 83 | / | 0.440 | |
| 3pcr | GTP | ADP-ribosylation factor 6 | / | 0.440 | |
| 3u2x | ASO | Glycogenin-1 | 2.4.1.186 | 0.440 | |
| 3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.440 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 4do3 | 0LA | Fatty-acid amide hydrolase 1 | 3.5.1.99 | 0.440 | |
| 4fd2 | ADP | Chaperone protein ClpB | / | 0.440 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
| 4r2m | ANP | Universal stress protein F | / | 0.440 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.440 |